Regorafenib in combination with TAS-102 for patients with metastatic colorectal cancer refractory to standard therapies: a prospective, single-arm, multi-center, phase II study
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/87868
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Group of colorectal cancer:Regorafenib plus TAS-102
Primary outcome(s): progression-free survival
Study Design: Single arm
创建时间：
2022-04-15
